ArticleReviews in cardiovascular medicine2026
Prognostic Value of the Blood Urea Nitrogen-to-Albumin Ratio (BAR) for Long-Term Survival Outcomes Among ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.
Article in Reviews in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The blood urea nitrogen-to-albumin ratio (BAR) has emerged as an independent prognostic marker of mortality in acute myocardial infarction (AMI). This study aimed to clarify the association between BAR and long-term survival outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). Methods: We retrospectively analyzed 1099 consecutive STEMI patients who underwent PPCI at the First Affiliated Hospital of Kunming Medical University between June 2018 and January 2023. Kaplan-Meier survival analysis and restricted cubic splines (RCS) were used to compare mortality among patients. Cox regression and subgroup analyses were performed to assess the associations between the BAR and the prespecified endpoints. The predictive efficacy of the BAR was quantified using receiver operating characteristic (ROC) curve analysis. Results: Patients with higher and elevated BARs had exhibited significantly worse long-term outcomes. After adjusting for confounders, the BAR remained an independent predictor of all-cause mortality (hazard ratio (HR) = 1.118, 95% confidence interval (CI): 1.049-1.193, Conclusions: The BAR is an independent prognostic biomarker for long-term all-cause and cardiovascular mortality in STEMI patients post-PPCI, highlighting the potential clinical utility of this ratio for in risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.